
A new recall of injected penicillin may put gains against syphilis in peril
The news – the latest twist in a drug shortage that began in 2023 – follows a July 10 recall of certain lots of Bicillin L-A that were found to be contaminated with floating particles. Pfizer says it has not received any reports of adverse events related to the recalled shots.
'We have identified the root cause to be associated with stoppers supplied from an external vendor and are implementing the appropriate corrective and preventative actions,' the company said in a statement, adding that it places the utmost emphasis on patient safety. 'We fully recognize the importance of this medicine for patients and are working as quickly as possible to resolve the matter.'
Benzathine penicillin G, sold as Bicillin, is used to treat a number of common bacterial infections, such as strep throat, in adults and children. Because one shot can last up to two weeks, it's especially helpful for people who can't swallow pills or may not be able to remember to take them. In most cases, however, if the shots aren't available, doctors can turn to alternatives like the antibiotic doxycycline.
But benzathine penicillin G is the only product that's approved and recommended to treat the sexually transmitted infection syphilis during pregnancy. If the infection is caught early, a single injection can keep the infection from spreading to a newborn, a condition called congenital syphilis.
Without treatment, syphilis during pregnancy can cause miscarriages and stillbirths. It can also be fatal for infants. Syphilis can also cause vision and hearing problems in babies as well as deformities of the bones and teeth.
As rates of syphilis rose in adults, more babies became infected, too. Over the past decade, rates of congenital syphilis have increased tenfold in the United States, from 335 in 2012 to more than 3,800 in 2023, according to data from the US Centers for Disease Control and Prevention.
'We're in the midst of a congenital syphilis crisis, and we've been calling for an emergency declaration for congenital syphilis for years,' said Dr. Jeffrey Klausner, a professor of clinical population and public health sciences at the University of Southern California's Keck School of Medicine. 'This threatens to make that even worse.'
The shot has been a key part of the strategy that some states have been using to quell rising rates of congenital syphilis.
Because too many pregnant patients infected with syphilis weren't making it into basic primary care, there's been a push in states including New Mexico and Minnesota to test all pregnant women for syphilis at multiple stages of pregnancy and whenever they show up in emergency rooms or urgent care clinics.
After an initial positive test, providers are encouraged to treat a pregnant patient with a shot of long-acting penicillin at the same visit, without waiting for the results of a second confirmatory test.
This push for one-stop testing and treatment has already had an effect.
'With the latest release of data, we saw a slowing of rates, which was really exciting,' said a CDC official familiar with the data who asked not to be named because they weren't authorized to speak to the media. That progress is the result of hard work bringing awareness to controlling syphilis and congenital syphilis, the official said.
Bicillin L-A most recently went into shortage in 2023. During that time, the US Food and Drug Administration has allowed imports of two equivalent products, a French drug called Extencilline, and Lentocilin, which is imported from Portugal and sold by entrepreneur Mark Cuban's Cost Plus Drugs. These imports continue to be authorized.
Those forms of the medication are trickier to use, said Erin Fox, associate chief pharmacy officer at the University of Utah Health.
'In a health system, it's very hard to use imported products,' she said. The bar coding on the drugs isn't recognized by most hospital systems, and there may be differences in how the products are mixed and diluted, which can be confusing.
Her hospital has been handling the shortage by being judicious about who gets Bicillin shots. It hasn't had to use an imported products yet.
Pfizer has also been working to boost its supply. The company stopped shipping pediatric doses in 2023 and instead focused on making adult doses to prioritize supply for pregnant patients. According to the FDA's drug shortage website, Pfizer expected to have a delivery of pediatric doses available in October.
Now, the company has advised customers that it will give an update on the Bicillin supply no later than mid-August. Until stock has fully recovered, Pfizer said, it will ration available supplies of the shots. Providers will have to fill out medical request forms, and the company will send supplies on a per-patient basis.
Sterile injectable products like Bicillin are especially vulnerable to shortages because they have a more complex manufacturing process than pills and tend to be prone to quality control issues. In this case, Pfizer is the sole supplier of Bicillin for the US.
The nonprofit National Coalition of STD Directors said it's gathering information from members to understand how far-reaching the impact of the recall may be.
One of its committees met Monday, and all of the participants were in the process of returning Bicillin doses to Pfizer. One state returned about 800 vials, 'so we expect to hear this is widespread,' said Elizabeth Finley, senior director of communications and programs for the organization.
'We had a small reprieve for about, maybe a year, in terms of steady supply. And now this is just a complete kick in the teeth and really threatens our ability to prevent and control syphilis,' Klausner said.
The CDC had previously posted recommendations for caring for syphilis patients during the shortage, but that information has since been taken down. Fox, who investigates drug shortages for the Association of Health Systems Pharmacists, said she has asked the agency to repost it but hasn't received a response.
CDC staffers who work on syphilis control were hit hard by recent government layoffs, although about 200 were reinstated in June. Federal funding cuts have also hampered state and local efforts to control sexually transmitted infections.
The FDA updated its drug shortage page with links to Pfizer's recent guidance but has not posted Pfizer's recall announcement.
A spokesperson for the US Department of Health and Human services referred questions about the recall and potential supply problems to Pfizer.
'I am concerned though that now, with a cut in funds to national and local STD programs, that we will start to see a drop in testing for syphilis,' the CDC official said. 'Cuts to Medicaid and Medicare, as well as other programs, will be devastating for syphilis control.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 hours ago
- Yahoo
Pfizer and 3SBio conclude licensing deal for SSGJ-707
Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the development, production and commercialisation of 3SBio's bispecific antibody SSGJ-707. The antibody targets programmed cell death protein 1 and vascular endothelial growth factor and was developed using 3SBio's CLF2 platform. As part of the agreement, which was signed in May 2025, 3SBio will receive $1.25bn, along with a $100m equity investment from Pfizer. The agreement also includes an option for Pfizer to extend its licensing rights to include exclusive development and commercialisation of SSGJ-707 in China, for which Pfizer will pay up to $150m in option payments to 3SBio. Pfizer research and development chief scientific officer and president Chris Boshoff stated: 'We are excited to contribute our significant expertise and resources to rapidly advance the development of the SSGJ-707 programme, including novel combination strategies across a number of our major tumour areas of focus. 'This is an important candidate that combines two key targets in a promising class of medicines, complementing our antibody-drug conjugate portfolio and further demonstrating our commitment to advancing pioneering science to deliver transformative cancer medicines and new hope to people living with cancer.' SSGJ-707 is undergoing multiple clinical trials in China for metastatic colorectal cancer, non-small cell lung cancer (NSCLC) and gynaecological tumours. Interim Phase II data have shown positive outcomes regarding the efficacy and safety of SSGJ-707 as a single agent for patients with advanced NSCLC. Pfizer intends to manufacture the drug substance for the antibody in Sanford in the US state of North Carolina, and the drug product in Kansas. The clinical development plan for SSGJ-707 will involve trial centres in the US and globally, with a focus on the Phase III worldwide development plan for NSCLC as well as other solid tumours. "Pfizer and 3SBio conclude licensing deal for SSGJ-707" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten
Yahoo
18 hours ago
- Yahoo
Extreme heat is miserable and dangerous. It's also making us age faster
The soupy, smothering extreme heat that has scorched parts of the Northern Hemisphere this summer takes a hard toll on our bodies. It can make you feel nauseous, woozy and dehydrated. It can have pernicious health effects on multiple organs. But there's another, less well-known, impact of extreme heat: It makes you age faster. Prolonged exposure to soaring temperatures can cause a deterioration in our cells and tissues and speed up biological aging, according to a new and growing body of research. Chronological age refers to how long a person has lived, but biological — or 'epigenetic' — age measures how well our tissues and cells function. The difference between the two explains why sometimes someone's age does not seem to match their health and vitality. An accelerated biological age is the 'canary in the coal mine' for future risk of earlier onset of diseases such as cancer, dementia and diabetes, and early death, said Jennifer Ailshire, professor of gerontology and sociology at the University of Southern California Leonard Davis School of Gerontology. As climate change forces people to endure increasingly severe and longer lasting heat waves, scientists say there is an urgency to better understand the ways heat is slowly and silently undermining human health at a cellular level. How does heat accelerate aging? Our DNA is set at birth; it is the blueprint for how the body functions and cannot be changed. But the way DNA is expressed — the way this blueprint is carried out — can be affected by external factors that trigger chemical modifications that turn genes on or off like a light switch. External factors affecting these switches include behaviors, such as smoking and lack of exercise, as well as environmental factors, like heat. Heat stresses the body, making it work harder as it tries to cool down, which can damage cells. While a little bit of heat stress can be good for the body, helping increase resilience, prolonged exposure taxes the body over extended periods and can have long-term consequences. Research on animals has pointed to strong associations between heat and accelerated aging but, until recently, there were very few studies that looked at humans. Ailshire is one of the scientists trying to change that. She and another researcher, Eunyoung Choi, published the first population-scale research into this area in February. They analyzed blood samples taken from a group of more than 3,600 people across the United States aged 56 and above. They used tools called 'epigenetic clocks,' which capture the way DNA is modified and provide an estimate of biological age. They then linked this to daily climate data in participants' locations in the years before the blood samples were taken. Their results, published in February, found people who experienced at least 140 extreme heat days a year — when the heat index, a combination of temperature and humidity, was above 90 degrees Fahrenheit — aged up to 14 months faster than those in locations with less than 10 extreme heat days a year. This link between heat and biological aging remained even when taking into account individual factors such as exercise levels and income, although the study did not look at access to air conditioning or time spent outside. The strength of the association was significant, too. The results showed extreme heat had the same impact on aging as smoking or heavy alcohol use. Their findings are supported by other recent research. A 2023 study of more than 2,000 people in Germany found medium- and long-term exposure to heat was linked to accelerated biological aging. The impacts were particularly pronounced in women, who can be more vulnerable to heat as they tend to sweat less, meaning it's harder for them to cool down. People with diabetes or obesity were also more at risk, the study found. The effects can even start before birth. A 2024 study looked at accelerated biological aging in children in Kenya who were exposed to drought as fetuses. During pregnancy, their mothers endured heat, as well as dehydration and emotional distress. These factors can cause stress at a cellular level that needs to be repaired, which means less energy is available for other vital functions, potentially leading to accelerated aging, the study found. Heat stress can also reduce blood flow to the uterus and placenta. 'So we see an impact on growth that includes lower birth weights and an overall harder start to life — all of which can be reflected in faster biological aging,' said Bilinda Straight, a study author and a professor at the School of Environment, Geography, and Sustainability at Western Michigan University. What can people do? Thiese findings do not mean that everyone living in hot places will experience accelerated aging, Ailshire said. Each person has their own risk factors and there are ways to adapt. Access to cooling and avoiding exercise in the hottest parts of the day are important. Better nutrition, more exercise (in the cool parts of the day) and medication can also help, she added. Scientists have found drugs including metformin, prescribed for diabetes, and weight-loss medication Ozempic could slow aging. If people can change or find ways to adapt to their heat exposure levels, it may be possible to slow or reverse the accelerated aging process, Ailshire said. 'Because that's not permanent damage; it's an indicator of the potential for permanent damage. It doesn't necessarily signify that this damage has been done.' The area of study is very new. 'We are just at the start of understanding this process, particularly in humans,' Rongbin Xu, a research fellow at the School of Public Health and Preventive Medicine at Monash University in Australia. But as places warm up, and heat records continue to be smashed, scientists are going to have a lot more data about the myriad ways heat affects our bodies — and who is most vulnerable. 'If we can't do anything about rising temperatures, then at a minimum, we need to be increasing awareness and finding strategies,' Ailshire said. 'There has to be a way that we can get through this.' Solve the daily Crossword


CNN
19 hours ago
- CNN
Extreme heat is making us age faster. Here's how
The soupy, smothering extreme heat that has scorched parts of the Northern Hemisphere this summer takes a hard toll on our bodies. It can make you feel nauseous, woozy and dehydrated. It can have pernicious health effects on multiple organs. But there's another, less well-known, impact of extreme heat: It makes you age faster. Prolonged exposure to soaring temperatures can cause a deterioration in our cells and tissues and speed up biological aging, according to a new and growing body of research. Chronological age refers to how long a person has lived, but biological — or 'epigenetic' — age measures how well our tissues and cells function. The difference between the two explains why sometimes someone's age does not seem to match their health and vitality. An accelerated biological age is the 'canary in the coal mine' for future risk of earlier onset of diseases such as cancer, dementia and diabetes, and early death, said Jennifer Ailshire, professor of gerontology and sociology at the University of Southern California Leonard Davis School of Gerontology. As climate change forces people to endure increasingly severe and longer lasting heat waves, scientists say there is an urgency to better understand the ways heat is slowly and silently undermining human health at a cellular level. Our DNA is set at birth; it is the blueprint for how the body functions and cannot be changed. But the way DNA is expressed — the way this blueprint is carried out — can be affected by external factors that trigger chemical modifications that turn genes on or off like a light switch. External factors affecting these switches include behaviors, such as smoking and lack of exercise, as well as environmental factors, like heat. Heat stresses the body, making it work harder as it tries to cool down, which can damage cells. While a little bit of heat stress can be good for the body, helping increase resilience, prolonged exposure taxes the body over extended periods and can have long-term consequences. Research on animals has pointed to strong associations between heat and accelerated aging but, until recently, there were very few studies that looked at humans. Ailshire is one of the scientists trying to change that. She and another researcher, Eunyoung Choi, published the first population-scale research into this area in February. They analyzed blood samples taken from a group of more than 3,600 people across the United States aged 56 and above. They used tools called 'epigenetic clocks,' which capture the way DNA is modified and provide an estimate of biological age. They then linked this to daily climate data in participants' locations in the years before the blood samples were taken. Their results, published in February, found people who experienced at least 140 extreme heat days a year — when the heat index, a combination of temperature and humidity, was above 90 degrees Fahrenheit — aged up to 14 months faster than those in locations with less than 10 extreme heat days a year. This link between heat and biological aging remained even when taking into account individual factors such as exercise levels and income, although the study did not look at access to air conditioning or time spent outside. The strength of the association was significant, too. The results showed extreme heat had the same impact on aging as smoking or heavy alcohol use. Their findings are supported by other recent research. A 2023 study of more than 2,000 people in Germany found medium- and long-term exposure to heat was linked to accelerated biological aging. The impacts were particularly pronounced in women, who can be more vulnerable to heat as they tend to sweat less, meaning it's harder for them to cool down. People with diabetes or obesity were also more at risk, the study found. The effects can even start before birth. A 2024 study looked at accelerated biological aging in children in Kenya who were exposed to drought as fetuses. During pregnancy, their mothers endured heat, as well as dehydration and emotional distress. These factors can cause stress at a cellular level that needs to be repaired, which means less energy is available for other vital functions, potentially leading to accelerated aging, the study found. Heat stress can also reduce blood flow to the uterus and placenta. 'So we see an impact on growth that includes lower birth weights and an overall harder start to life — all of which can be reflected in faster biological aging,' said Bilinda Straight, a study author and a professor at the School of Environment, Geography, and Sustainability at Western Michigan University. Thiese findings do not mean that everyone living in hot places will experience accelerated aging, Ailshire said. Each person has their own risk factors and there are ways to adapt. Access to cooling and avoiding exercise in the hottest parts of the day are important. Better nutrition, more exercise (in the cool parts of the day) and medication can also help, she added. Scientists have found drugs including metformin, prescribed for diabetes, and weight-loss medication Ozempic could slow aging. If people can change or find ways to adapt to their heat exposure levels, it may be possible to slow or reverse the accelerated aging process, Ailshire said. 'Because that's not permanent damage; it's an indicator of the potential for permanent damage. It doesn't necessarily signify that this damage has been done.' The area of study is very new. 'We are just at the start of understanding this process, particularly in humans,' Rongbin Xu, a research fellow at the School of Public Health and Preventive Medicine at Monash University in Australia. But as places warm up, and heat records continue to be smashed, scientists are going to have a lot more data about the myriad ways heat affects our bodies — and who is most vulnerable. 'If we can't do anything about rising temperatures, then at a minimum, we need to be increasing awareness and finding strategies,' Ailshire said. 'There has to be a way that we can get through this.'